Concentration of chemokines in peripheral blood in first trimester of diabetic pregnancy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 87, Issue 1, 2008, Pages 14-19

  Wender Ozegowska, E ^a   Michalowska Wender G ^a,b   Zawiejska, A ^a   Pietryga, M ^a   Brazert, J ^a   Wender, M ^a,b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Chemokines; Diabetic pregnancy; IP 10; MCP 1; Miscarriage; MMP 9; RANTES

Indexed keywords

CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; FIRST TRIMESTER PREGNANCY; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOMODULATION; LOGISTIC REGRESSION ANALYSIS; MATERNAL BLOOD; METABOLISM; MICROALBUMINURIA; PERINATAL CARE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SPONTANEOUS ABORTION; T LYMPHOCYTE ACTIVATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHEMOKINES; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY TRIMESTER, FIRST; TRIGLYCERIDES;

EID: 37549032643     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701698724     Document Type: Article

References (24)

1. Nagaoka K, Nojima H, Watanabe F, Chang KT, Christenson RK, Imakowa K. Regulation of blastocyst migration, apposition, and initial adhesion by a chemokine, interferon gamma-inducible protein 10 kDa (IP-10), during early gestation. J Biol Chem. 2003;31:29048-56.
2. Wood GW, Hausmann E, Choudhuri R. Relative role of CSF-1, MCP-1/JE, and RANTES in macrophage recruitment during successful pregnancy. Mol Reprod Dev. 1997;1:62-9.
3. Loke YW, King A. Immunology of human implantation: an evolutionary perspective. Hum Reprod. 1996;11:283-6.
4. Mackay C. Chemokines: immunology's high impact factors. Nat Immunol. 2001;2:95-101.
5. Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppeheim JJ, et al. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by interleukin (IL-1) and tumor necrosis factor (TNF-α). J Immunol. 1990;144:3034-8.
6. Ramhorst RE, Garcia VE, Corigliano A, Rabinovich GA, Fainboim L. Reprod fertile DevRANTES as a novel immunomodulator of the maternal allogenic response. Clin Immunol. 2004;1:71-8.
7. Denison FC, Kelly RW, Calder AA. Differential secretion of chemokines from peripheral blood in pregnant compared to non-pregnant women. J Reprod Med. 1997;3:225-40.
8. Inagaki N, Stern C, McBain J, Lopata A, Kornman L, Wilkinson D. Analysis of intra-uterine cytokine concentration and matrix-metalloproteinase activity in women with recurrent failed embryo transfer. Hum Reprod. 2003;18:608-15.
9. Hurst PR, Palmay RD. Matrix metalloproteinases and their endogenous inhibitors during the implantation period in the rat uterus. Reprod Fertil Dev. 1999;11:395-402.
10. Romero R, Chaiworapongsa T, Espinoza J, Gomez R, Yoon BH, Edwin S, et al. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol. 2002;187:1125-30.
11. Konishi H, Nakatsuka M, Chekir C, Noguchi S, Kamada Y, Sasaki A, et al. Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts. Hum Reprod. 2004;9:2156-62.
12. Maxwell PR, Timms PM, Chandran S, Gordon D. Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes. Diabetes Med. 2001;18:777-80.
13. Pustovrh MC, Jawerbaum A, Capobianco E, White V, Martinez N, Lopez-Costa JJ, et al. Oxidative stress promotes the increase of matrix metalloproteinases-2 and -9 activities in the feto-placental unit of diabetic rats. Free Radic Res. 2005;39:1285-93.
14. Pustovrh MC, Jawerbaum A, Capobianco E, White V, Lopez-Costa JJ, Gonzalez E. Increased matrix metalloproteinases 2 and 9 in placenta of diabetic rats at midgestation. Placenta. 2005;26:339-48.
15. 1C assay. Clin Chem. 1996;42:116 (Abstract 094).
16. 1C estimation. Clin Chem Lab Med. 2002;40:78-89.
17. Greene MF. Spontaneous abortions and major malformations in women with diabetes mellitus. Semin Reprod Endocrinol. 1999;17:127-36.
18. Wender-Ożegowska E, Koźlik J, Biczysko R, Ożegowski S. Changes of oxidative parameters in diabetic pregnancy. Free Radic Res. 2004;8:795-803.
19. Ang C, Hillier C, Cameron AD, Greer IA, Lumsden MA. The effect of type 1 diabetes mellitus on vascular responses to endothelin-1 in pregnant women. J Clin Endocrinol Metab. 2001;86:4939-42.
20. Baumgartner-Parzer SM, Waldhaeusl WK. The endothelium as a metabolic and endocrine organ: its relation with insulin resistance. Exp Clin Endocrinol Diabetes. 2001;109(Suppl 2):S166-79.
21. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129-46.
22. Garcia-Velasco JA, Arici A. Chemokines and human reproduction. Fertil Steril. 1999;71:983-93.
23. Ramhorst RE, Garcia VE, Corigliano A, Rabinovich GA, Fainboim I. Identification of RANTES as a novel immunomodulator of the maternal allogeneic response. Clin Immunol. 2004;1:71-80.
24. Robertson SA, Mau VJ, Hudson SN, Tremellen KP. Cytokine-leukocyte networks and the establishment of pregnancy. Am J Reprod Immunol. 1997;6:438-42.